🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study is to better understand the influence of insuli...
Status
Completed
Location
Multiple Locations
Start Date
2002-04
Trial ID
NCT00351871
Treatments Being Tested
Hepatitis C virus (HCV) infection is a leading cause of death and illness i...
Status
Completed
Location
Alabama CRS
Start Date
2012-04
Trial ID
NCT01482767
Treatments Being Tested
The purpose of this study is to evaluate the impact of a physician directed...
Status
Completed
Location
California Liver Institute
Start Date
2011-12
Trial ID
NCT01405027
Treatments Being Tested
The role of the dendritic cells, the most potent antigen presenting cells, ...
Status
Completed
Location
University College Hospital
Start Date
2002-04
Trial ID
NCT00723242
Treatments Being Tested
The purpose of this 12-week study was to assess in subjects with chronic he...
Status
Completed
Location
Tokuda Hospital
Start Date
2009-07
Trial ID
NCT00953589
Treatments Being Tested
This sudy will determine whether shortening treatment for hepatitis C is fe...
Status
Completed
Location
Hunter Pharmacotherapy
Start Date
2012-06
Trial ID
NCT01364090
Treatments Being Tested
This study is divided into 2 segments, and proposes to qualify fine needle ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2012-05
Trial ID
NCT01547312
The objective is to evaluate the efficacy and safety of the combination the...
Status
Completed
Location
Multiple Locations
Start Date
2008-01
Trial ID
NCT00686777
Treatments Being Tested
This is a Phase IIIB, randomized, prospective, multicenter, single-country,...
Status
Completed
Location
Multiple Locations
Start Date
2005-07-18
Trial ID
NCT00237484
The objective of the study is to select an optimal dose of taribavirin by c...
Status
Completed
Location
Cedars-Sinai Medical Center, 8635 W. 3rd Street, Suite 590W
Start Date
2007-03
Trial ID
NCT00446134
Treatments Being Tested